Auspex Pharmaceuticals (ASPX) : 4-month performance

• Auspex Pharmaceuticals (ASPX) was acquired by Teva for $3.5 billion, (30 March 2015)

Auspex Pharmaceuticals Inc (ASPX) began trading on the NASDAQ on 5 February 2014

The San Diego-based company develops drugs for rare diseases, such as involuntary movement associated with brain disorder Huntington's disease. It raised $84 million after offering 7 million shares at $12 per share. Auspex plans to use the money raised to develop drugs and continue clinical trials. Its stock, which is listed on the Nasdaq stock exchange under the ticker symbol "ASPX," rose $3.66, or 30.5 percent, to close at $15.66.

Address

3366 North Torrey Pines Court, Suite 225
LA JOLLA, CA 92037
United States

Website 

http://www.auspexpharma.com